Abbott to Present at Merrill Lynch Healthcare Conference |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Abbott Laboratories
100 Abbott Park Rd., AP Abbott Park 5, Dept. 209
Abbott Park, IL, 60064
USA
Press release date: January 29, 2008
ABBOTT PARK, Ill., Jan. 29 / -- Abbott will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Tuesday, Feb. 5, 2008. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at 9:20 a.m. Central time.
A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com/. An archived edition of the presentation will be available later that day.
Abbott (NYSE:ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries. Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com/.
FCMN Contact: anita.duncan@abbott.com
Source: Abbott
CONTACT: Media, Scott Stoffel +1-847-936-9502
Web site: http://www.abbott.com/
|
|
|
|
|
|
| 
